Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 4
2018 4
2019 6
2020 8
2021 9
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
Kerekes G, Czókolyová M, Hamar A, Pusztai A, Tajti G, Katkó M, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Hascsi Z, Harangi M, Hodosi K, Panyi G, Seres T, Szűcs G, Szekanecz Z. Kerekes G, et al. Among authors: hodosi k. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI304-SI312. doi: 10.1093/rheumatology/kead502. Rheumatology (Oxford). 2023. PMID: 37871914 Free PMC article.
Associations of vascular and bone status in arthritis patients.
Pusztai A, Hamar A, Czókolyová M, Gulyás K, Horváth Á, Végh E, Pethő Z, Szamosi S, Balogh E, Bodnár N, Bodoki L, Szentpétery Á, Bhattoa HP, Kerekes G, Juhász B, Szekanecz É, Hodosi K, Domján A, Szántó S, Raterman HG, Lems WF, Szekanecz Z, Szűcs G. Pusztai A, et al. Among authors: hodosi k. Sci Rep. 2021 Sep 30;11(1):19504. doi: 10.1038/s41598-021-99071-9. Sci Rep. 2021. PMID: 34593938 Free PMC article.
Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Soós B, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Csongrádi A, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szekanecz É, Szamosi S, Szántó S, Szűcs G, Papp Z, Szekanecz Z. Soós B, et al. Among authors: hodosi k. Front Med (Lausanne). 2022 Jan 27;8:785744. doi: 10.3389/fmed.2021.785744. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155468 Free PMC article.
Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.
Kacsándi D, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Soós B, Szabó AÁ, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szamosi S, Szűcs G, Papp Z, Szekanecz Z. Kacsándi D, et al. Among authors: hodosi k. Front Med (Lausanne). 2023 Oct 9;10:1226760. doi: 10.3389/fmed.2023.1226760. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37877017 Free PMC article.
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.
Hamar A, Szekanecz Z, Pusztai A, Czókolyová M, Végh E, Pethő Z, Bodnár N, Gulyás K, Horváth Á, Soós B, Bodoki L, Bhattoa HP, Nagy G, Tajti G, Panyi G, Szekanecz É, Domján A, Hodosi K, Szántó S, Szűcs G, Szamosi S. Hamar A, et al. Among authors: hodosi k. Osteoporos Int. 2021 Aug;32(8):1621-1629. doi: 10.1007/s00198-021-05871-0. Epub 2021 Feb 9. Osteoporos Int. 2021. PMID: 33559714 Free PMC article.
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.
Czókolyová M, Hamar A, Pusztai A, Tajti G, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Szentpéteri A, Seres I, Harangi M, Paragh G, Kerekes G, Bodoki L, Domján A, Hodosi K, Seres T, Panyi G, Szekanecz Z, Szűcs G. Czókolyová M, et al. Among authors: hodosi k. Biomolecules. 2022 Oct 14;12(10):1483. doi: 10.3390/biom12101483. Biomolecules. 2022. PMID: 36291691 Free PMC article.
35 results